Skip Header

 

1 - 25 of 67 results for author:"Fukushima T."Drop in Literature Citations

Customize display Download...

Page of 3 | Next »

Hepatocyte growth factor activator is a serum activator of single-chain precursor macrophage-stimulating protein.

Kawaguchi M., Orikawa H., Baba T., Fukushima T., Kataoka H.

FEBS J. 276:3481-3490(2009) · Mapped (9)

Hepatic interleukin-7 expression regulates T cell responses.

Sawa Y., Arima Y., Ogura H., Kitabayashi C., Jiang J.J., Fukushima T., Kamimura D., Hirano T., Murakami M.

Immunity 30:447-457(2009) · Mapped (7)

Hepatocyte growth factor activator inhibitor type 1 regulates epithelial to mesenchymal transition through membrane-bound serine proteinases.

Cheng H., Fukushima T., Takahashi N., Tanaka H., Kataoka H.

Cancer Res. 69:1828-1835(2009) · Mapped (4)

Tissue injury alters the site of expression of hepatocyte growth factor activator inhibitor type 1 in bronchial epithelial cells.

Tanaka H., Fukushima T., Yorita K., Kawaguchi M., Kataoka H.

Hum. Cell 22:11-17(2009) · Mapped (4)

Defect of hepatocyte growth factor activator inhibitor type 1/serine protease inhibitor, Kunitz type 1 (Hai-1/Spint1) leads to ichthyosis-like condition and abnormal hair development in mice.

Nagaike K., Kawaguchi M., Takeda N., Fukushima T., Sawaguchi A., Kohama K., Setoyama M., Kataoka H.

Am. J. Pathol. 173:1464-1475(2008) · Mapped (25)

Impaired TCR signaling through dysfunction of lipid rafts in sphingomyelin synthase 1 (SMS1)-knockdown T cells.

Jin Z.X., Huang C.R., Dong L., Goda S., Kawanami T., Sawaki T., Sakai T., Tong X.P., Masaki Y., Fukushima T. et al.

Int. Immunol. 20:1427-1437(2008) · Mapped (3)

Expression of hepatocyte growth factor activator inhibitor type 1 on the epithelial cell surface is regulated by hypoxic and oxidative stresses.

Komaki W., Fukushima T., Tanaka H., Itoh H., Chosa E., Kataoka H.

Virchows Arch. 453:347-357(2008) · Mapped (4)

Fatal sibling cases of familial hemophagocytic lymphohistiocytosis (FHL) with MUNC13-4 mutations: case reports.

Nakao T., Shimizu T., Fukushima T., Saito M., Okamoto M., Sugiura M., Yamamoto K., Ueda I., Imashuku S., Kobayashi C. et al.

Pediatr Hematol Oncol 25:171-180(2008) · Mapped (2)

Expression of myeloperoxidase enhances the chemosensitivity of leukemia cells through the generation of reactive oxygen species and the nitration of protein.

Sawayama Y., Miyazaki Y., Ando K., Horio K., Tsutsumi C., Imanishi D., Tsushima H., Imaizumi Y., Hata T., Fukushima T. et al.

Leukemia 22:956-964(2008) · Mapped (2)

Activation of hepatocyte growth factor activator zymogen (pro-HGFA) by human kallikrein 1-related peptidases.

Mukai S., Fukushima T., Naka D., Tanaka H., Osada Y., Kataoka H.

FEBS J. 275:1003-1017(2008) · Mapped (19)

Roles of insulin-like growth factor binding protein-2 (IGFBP-2) in glioblastoma.

Fukushima T., Kataoka H.

Anticancer Res. 27:3685-3692(2007) · Mapped (2)

Enhancement of synaptic transmission and nociceptive behaviour in HPC-1/syntaxin 1A knockout mice following peripheral nerve injury.

Takasusuki T., Fujiwara T., Yamaguchi S., Fukushima T., Akagawa K., Hori Y.

Eur. J. Neurosci. 26:2179-2187(2007) · Mapped (1)

Phylogenetic relationships within the family Halobacteriaceae inferred from rpoB' gene and protein sequences.

Enache M., Itoh T., Fukushima T., Usami R., Dumitru L., Kamekura M.

Int. J. Syst. Evol. Microbiol. 57:2289-2295(2007) · UniProtKB (16)

Characterization of new L,D-endopeptidase gene product CwlK (previous YcdD) that hydrolyzes peptidoglycan in Bacillus subtilis.

Fukushima T., Yao Y., Kitajima T., Yamamoto H., Sekiguchi J.

Mol. Genet. Genomics 278:371-383(2007) · UniProtKB (1)

Aberrant hypermethylation of p14ARF and O6-methylguanine-DNA methyltransferase genes in astrocytoma progression.

Watanabe T., Katayama Y., Yoshino A., Yachi K., Ohta T., Ogino A., Komine C., Fukushima T.

Brain Pathol. 17:5-10(2007) · Mapped (10)

Silencing of insulin-like growth factor-binding protein-2 in human glioblastoma cells reduces both invasiveness and expression of progression-associated gene CD24.

Fukushima T., Tezuka T., Shimomura T., Nakano S., Kataoka H.

J. Biol. Chem. 282:18634-18644(2007) · Mapped (4)

Ubiquitin-conjugating enzyme Ubc13 is a critical component of TNF receptor-associated factor (TRAF)-mediated inflammatory responses.

Fukushima T., Matsuzawa S., Kress C.L., Bruey J.M., Krajewska M., Lefebvre S., Zapata J.M., Ronai Z., Reed J.C.

Proc. Natl. Acad. Sci. U.S.A. 104:6371-6376(2007) · Mapped (1)

Induction of human adiponectin gene transcription by telmisartan, angiotensin receptor blocker, independently on PPAR-gamma activation.

Moriuchi A., Yamasaki H., Shimamura M., Kita A., Kuwahara H., Fujishima K., Satoh T., Fukushima K., Fukushima T., Hayakawa T. et al.

Biochem. Biophys. Res. Commun. 356:1024-1030(2007) · Mapped (13)

Clinical relevance of hepsin and hepatocyte growth factor activator inhibitor type 2 expression in renal cell carcinoma.

Betsunoh H., Mukai S., Akiyama Y., Fukushima T., Minamiguchi N., Hasui Y., Osada Y., Kataoka H.

Cancer Sci. 98:491-498(2007) · Mapped (3)

Syntaxin 1A occludes GABA(B) receptor-induced inhibition of exocytosis downstream of Ca(2+) entry in mouse hippocampal neurons.

Fukushima T., Tsuda M., Otsubo T., Hori Y.

Neurosci. Lett. 415:130-134(2007) · Mapped (1)

Late-onset cases of familial hemophagocytic lymphohistiocytosis with missense perforin gene mutations.

Ueda I., Kurokawa Y., Koike K., Ito S., Sakata A., Matsumora T., Fukushima T., Morimoto A., Ishii E., Imashuku S.

Am. J. Hematol. 82:427-432(2007) · Mapped (1)

Promoter hypermethylation profile of cell cycle regulator genes in pituitary adenomas.

Yoshino A., Katayama Y., Ogino A., Watanabe T., Yachi K., Ohta T., Komine C., Yokoyama T., Fukushima T.

J. Neurooncol. 83:153-162(2007) · Mapped (25)

Expression and mutation of SMAD4 in poorly differentiated carcinoma and signet-ring cell carcinoma of the colorectum.

Seshimo I., Yamamoto H., Mishima H., Kurata A., Suzuki R., Ezumi K., Takemasa I., Ikeda M., Fukushima T., Tsujinaka T. et al.

J. Exp. Clin. Cancer Res. 25:433-442(2006) · Mapped (3)

Early changes in sperm motility, acrosome reaction, and gene expression of reproductive organs in rats treated with sulfasalazine.

Fukushima T., Hamada Y., Komiyama M., Matsuno Y., Mori C., Horii I.

Reprod. Toxicol. 23:153-157(2007) · Mapped (11)

Mutations in the SLC34A2 gene are associated with pulmonary alveolar microlithiasis.

Huqun, Izumi S., Miyazawa H., Ishii K., Uchiyama B., Ishida T., Tanaka S., Tazawa R., Fukuyama S., Tanaka T. et al.

Am. J. Respir. Crit. Care Med. 175:263-268(2007) · Mapped (2)

Page of 3 | Next »